Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MIC3046 Microbiota and Pathogens > Lecture A10 - Some Important Viruses Infecting Mucosal Sufaces > Flashcards

Lecture A10 - Some Important Viruses Infecting Mucosal Sufaces Flashcards

1
Q

Name some non-enveloped viruses that infect mucosal surfaces?

A

Rotavirus - dsDNA infects the digestive tract.
HPV - dsDNA infects the urogenital tract.
Norovirus - ssRNA infects the digestive tract.
Poliovirus - ssDNA infects the digestive tract.
Trichomonasvirus - dsRNA infects the urogenital tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Name some enveloped viruses that infect mucosal surfaces.

A

HIV - ssRNA infects the urogenital tract.
SARS-CoV-2 - ssRNA infects the respiratory tract.
Influenza - ssRNA infects the respiratory tract.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What viruses have effective vaccines?

A

Poliovirus, HPV, coronaviruses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What vaccines have variable efficacy?

A

Influenza, rotavirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What infections have no vaccines available?

A

HIV, norovirus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the 6 core features of effective vaccines?

A

Safe
Protective
Gives sustained protection
Induces neutralising antibody
Induces protective T cells
Practical considerations (low cost, ease of administration etc).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What type of vaccine is usually required for the digestive tract?

A

Oral.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the different types of administration for parenteral vaccines?

A

Intramuscular, subcutaneous, intravenous and intradermal.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the different delivery methods of vaccines?

A

Intranasal, sublingual, oral, rectal, intravaginal, parenteral.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How can systemic IgG and mucosal IgA be produced?

A

Via the combination of the mucosal and parenteral vaccines.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the difference between mucosal and parenteral vaccines?

A

Parenteral injected vaccines give systemic immune responses.
Mucosal vaccines give rise to both mucosal and systemic immune responses.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Why might the urogenital and lower respiratory tracts may also be effectively treated by parenteral vaccines?

A

These mucosa are permeable to serum IgG.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is a live attenuated vaccine?

A

Specific part of the virus cloned and purified. It is then sub cloned as a slightly different version of the virus so that illness is not caused by the virus when it is administered.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is an inactive attenuated vaccine?

A

The virus is chemically killed (fixed) so the virus is not pathogenic but is still a whole thing that will be recognised by the immune response to stimulate a response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name three examples of live attenuated vaccines, their entry route and trade name.

A

Polio (OPV) - oral - many trade names
Rotavirus (monovalent human rotavirus strain) - oral - RotaRix
Influenza (cold-adapted influenza virus reassortant strain) - nasal - FluMist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe poliovirus.

A

Non-enveloped, spherical, pseudo3 icosahedral capsid surrounding the naked RNA genome. Capsid consists of a densely packed icosahedral arrangement of 60 promoters, each consisting of 4 polypeptides (VP1, VP2, VP3, VP4). VP4 is located on the internal side of the capsid.
ssRNA.

16
Q

Describe rotavirus.

A

Non enveloped icosahedral non-turreted vision with a triple capsid structure. Intermediate capsid has a 13 icosahedral symmetry, the inner capsid has 2 icosahedral symmetry.
dsRNA.

17
Q

Describe norovirus.

A

Non enveloped capsid with 3 icosahedral symmetry. Capsid is composed of 180 VP1 proteins. Small empty virions are 23nm in diameter and would be 1 icosahedral symmetry composed of 60 VP1 proteins.
ssRNA.

18
Q

What are the 2 vaccines for polio?

A

Oral polio vaccine and the inactivated polio vaccine.
Combination of both of these vaccines basically eradicated polio from the world.

19
Q

Describe the inactivated polio vaccine.

A

No risk of vaccine related paralytic polio (VAPP).
Does not stimulate antibodies in the gut.
Protects only the immunised, no community benefits.
More expensive than the oral as requires a sterile syringe.

20
Q

Describe the oral polio vaccine.

A

Cheap and ideal for mass vaccination.
Immunological response in both the gut and systemic tissues.
Provides community benefits.
Small risk of VAPP.

21
Q

What is the 3 modes of action of neutralising antibodies?

A

Block attachment
Block endocytosis
Block uncoating.

22
Q

Describe the epidemiology of rotavirus.

A

Most important cause of diarrhoeal mortality in children below 2.
450,000 children deaths per year.
>90% of death cases due to this virus occur in Africa and Asia (resource limited contexts).
2 licensed oral vaccines.

23
Q

What is the principle effector of long-term protection against rotavirus?

A

SIgA neutralises it.
There is a role in endoscopes reducing viral replication for anti-VP6 antibodies.
Anti VP4 and VP7 antibodies support a neutralising role in the lumen.
Such antibodies reduce initial infections and interfere with ongoing infections.

24
Q

What is RotaRix?

A

An attenuated human virus vaccine for rotavirus.

25
Q

What is RotaTeq?

A

A cocktail of cattle-human hybrid virus vaccine for rotavirus,

26
Q

Why are the rotaviruses vaccines not enough on their own?

A

They have variable efficacies and are not a solution to eradicate the virus. An integrated approach of combining improved nutrition, access to clean water and better sanitation and hygiene are needed.

27
Q

Describe orthomyxoviridae.

A

Enveloped, usually rounded but can be filamentous.
ssRNA
Human to human transmission, animal to human transmission, human to animal transmissions.
Mixing between human and animal variants can lead to the production of new types of viruses.

28
Q

What is antigenic shift?

A

Major change in influenza virus antigen due to gene reassortment

29
Q

What is antigenic drift?

A

Minor change in influenza virus antigens due to gene mutation

30
Q

Why do we need an updated vaccine for influenza each year?

A

Influenza is a highly variable virus due to antigenic shift and drift. Outbreaks occur annually due to the plasticity of the genome so constantly need an updated vaccine to be able to be effective against the new version of the virus.

31
Q

Describe betacoronavirus.

A

Enveloped, RNA genome associated with the N protein to form the nucleocapsid.
ssRNA, has a membrane but it is non segmented.

32
Q

Who are more vulnerable to becoming seriously ill and die from coronavirus and why?

A

Elderly people and those with pre-existing medical conditions and people with comorbidiities. Key factor could be the loss of microbial diversity associated with ageing and with it a higher susceptibility to inflammation.

33
Q

What are some drug/antibody treatments for covid?

A

Antivirals - virus particles multiply inside the body, antiviral drugs prevents the virus from multiplying.
Anti-inflammatories - immune system overreacts to the virus, anti-inflammatories calms the immune response.
Antibody treatments - antibody specific to coronavirus to bind and kill it.

34
Q

What type were the 2 vaccines for covid?

A

Modified DNA virus vaccine.
mRNA vaccine.

35
Q
A

MIC3046 Microbiota and Pathogens (20 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions